Itron (NASDAQ:ITRI) CFO Joan Hooper Sells 355 Shares

Itron, Inc. (NASDAQ:ITRI) CFO Joan Hooper sold 355 shares of Itron stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total value of $28,258.00. Following the sale, the chief financial officer owned 117,920 shares in the company, valued at $9,386,432. The trade was a 0.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Price Performance

ITRI opened at $81.85 on Friday. The firm has a market cap of $3.63 billion, a P/E ratio of 13.05, a PEG ratio of 0.71 and a beta of 1.35. The firm has a 50-day moving average of $88.63 and a 200 day moving average of $94.60. The company has a debt-to-equity ratio of 0.97, a quick ratio of 2.24 and a current ratio of 2.66. Itron, Inc. has a fifty-two week low of $77.77 and a fifty-two week high of $142.00.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.26 by $0.23. The business had revenue of $586.98 million for the quarter, compared to analyst estimates of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, research analysts expect that Itron, Inc. will post 6.01 EPS for the current year.

Trending Headlines about Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and kept a $130 price target, implying substantial upside from the current share price. Stephens reaffirms Overweight on Itron
• Neutral Sentiment: Several Itron executives sold small blocks of shares, but the filings say the transactions were mainly to cover tax withholding from equity award vesting, which makes the insider activity less concerning than open-market selling. SEC filing for insider sale
• Negative Sentiment: Zacks Research cut multiple earnings estimates for Itron, including a sharp reduction for Q4 2027 and a lower FY2027 forecast, signaling softer profit expectations ahead. Zacks Research estimate cuts for Itron

Analyst Ratings Changes

ITRI has been the topic of several research analyst reports. JPMorgan Chase & Co. dropped their price objective on Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Oppenheimer boosted their target price on Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Stephens reiterated an “overweight” rating and set a $130.00 price target on shares of Itron in a research note on Wednesday. Finally, Needham & Company LLC started coverage on Itron in a report on Friday, March 6th. They issued a “buy” rating and a $124.00 price objective for the company. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Itron currently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Institutional Investors Weigh In On Itron

Institutional investors have recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Itron by 343.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after acquiring an additional 268 shares during the period. M&T Bank Corp raised its stake in shares of Itron by 10.0% during the 2nd quarter. M&T Bank Corp now owns 2,141 shares of the scientific and technical instruments company’s stock valued at $282,000 after purchasing an additional 194 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares in the last quarter. Jump Financial LLC bought a new position in Itron in the 2nd quarter worth about $1,609,000. Finally, Cerity Partners LLC boosted its stake in Itron by 10.2% in the 2nd quarter. Cerity Partners LLC now owns 5,431 shares of the scientific and technical instruments company’s stock worth $715,000 after purchasing an additional 503 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.